9Silvestri A, Vitale C, Ferretti F, et al. Plasma level of inflammatory C-re- active protein and interleukin-6 predict outcome in elderly patients with stroke [J].J Am Gefiatr Soc,2004 ;52 ( 9 ) : 1586-7.
二级参考文献46
1Eknoyan G, Beck GJ, Cheung AK, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med, 2002,347(25):2010-2019.
2Paniagua R, Amato D, Vonesh E, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol, 2002,13(5):1307-1320.
3Cheung AK, Sarnak MJ, Yan G, et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int, 2000,58:353-562.
4Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med, 1999, 340(2): 115-126.
5Memoli B, Postiglione L, Cianciaruso B, et al. Role of different dialysis membranes in the release of interleukin-6 soluble receptor in uremic patients. Kidney Int, 2000,58:417-424.
6Shlipak MG, Fried LF, Crump C, et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation, 2003, 107: 87-92.
7Svensson M, Yu ZW, Eriksson JW. A small reduction in glomerular filtration is accompanied by insulin resistance in type 1 diabetes mellitus patients with diabetic nephropathy. Eur J Clin Invest, 2002,32:100-109.
8Panichi V, Migliori M, De Pietro S, et al. C-reactive protein and interleukin-6 levels are related to renal function in predialytic chronic renal failure. Nephron, 2002, 91(4): 594-600.
9Pecoits-Filho R, Goncalves S, Barberato SH, et al. Impact of Residual Renal Function on Volume Status in Chronic Renal Failure. Blood Purif, 2004,22(3):285-292.
10Niebauer J, Volk HD, Kemp M, et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet, 1999,353(9167):1838-1842.
4Uchida E,Anan F,Masaki T,et al.Monocyte chemoattractant protein-1 is associated with silent cerebral infarction in patients on haemodialysis(J).Int Med J,2012;42(1):29-34.
5Vermeer SE,Den Hetjer T,Kudstoal PJ,et al.Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan study(J).Stroke,2003;34(2):392-6.
6US Renal Data System.Experts from the United States Renal Data System's 2002 Annual Data Report:Atlas of End-Stage Renal Disease in the United States(J).Am J Kidney Dis,2003;41(Suppl 2):S8-S256.
7Arizono K,Nomura K,Motoyama T,et al.Use of ultrapure dialysate in re-duction of chronic inflammation during hemodialysis(J).Blood Purif,2004;22(Suppl 2):26-9.
8Lederer SR,Schiffl H.Ultrapured dalysis fluid lowers the cardiovascular morbidity in patients on maintenance hemodialysis by reducing continuous microinflammation(J).Nephron,2002;91(3):452-5.
9Akeda A,Toda T,Fujii T,et al.Discordance of influence of hypertension on mortality and cardiovascular risk in hemodialysis patients(J).Am J Kidney Dis,2005;45:112-8.
10Gudmundsson P, Olesen P.I, Simoni M, et al.White matter lesions and temporal lobe atrophy related to incidence of both dementia and major depression in 70-year-olds followed over 10 years[J]. Eur J Neurol, 2015, 22 (5) : 781-e50.
